Next Article in Journal
Unraveling LMNA Mutations in Metabolic Syndrome: Cellular Phenotype and Clinical Pitfalls
Next Article in Special Issue
Mitophagy in Acute Kidney Injury and Kidney Repair
Previous Article in Journal
Angiogenic Effects of Human Dental Pulp and Bone Marrow-Derived Mesenchymal Stromal Cells and their Extracellular Vesicles
Previous Article in Special Issue
Autophagy and Macrophage Functions: Inflammatory Response and Phagocytosis

Targeting Aggrephagy for the Treatment of Alzheimer’s Disease

Mr. and Mrs. Ko Chi Ming Centre for Parkinson’s Disease Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
Medical College of Acupuncture-Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
Author to whom correspondence should be addressed.
Cells 2020, 9(2), 311;
Received: 1 December 2019 / Revised: 25 January 2020 / Accepted: 26 January 2020 / Published: 28 January 2020
(This article belongs to the Special Issue Advances in Selective Autophagy)
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases in older individuals with specific neuropsychiatric symptoms. It is a proteinopathy, pathologically characterized by the presence of misfolded protein (Aβ and Tau) aggregates in the brain, causing progressive dementia. Increasing studies have provided evidence that the defect in protein-degrading systems, especially the autophagy-lysosome pathway (ALP), plays an important role in the pathogenesis of AD. Recent studies have demonstrated that AD-associated protein aggregates can be selectively recognized by some receptors and then be degraded by ALP, a process termed aggrephagy. In this study, we reviewed the role of aggrephagy in AD development and discussed the strategy of promoting aggrephagy using small molecules for the treatment of AD. View Full-Text
Keywords: aggrephagy; selective autophagy; Alzheimer’s disease; aggregates aggrephagy; selective autophagy; Alzheimer’s disease; aggregates
Show Figures

Figure 1

MDPI and ACS Style

Malampati, S.; Song, J.-X.; Chun-Kit Tong, B.; Nalluri, A.; Yang, C.-B.; Wang, Z.; Gopalkrishnashetty Sreenivasmurthy, S.; Zhu, Z.; Liu, J.; Su, C.; Krishnamoorthi, S.; Iyaswamy, A.; Cheung, K.-H.; Lu, J.-H.; Li, M. Targeting Aggrephagy for the Treatment of Alzheimer’s Disease. Cells 2020, 9, 311.

AMA Style

Malampati S, Song J-X, Chun-Kit Tong B, Nalluri A, Yang C-B, Wang Z, Gopalkrishnashetty Sreenivasmurthy S, Zhu Z, Liu J, Su C, Krishnamoorthi S, Iyaswamy A, Cheung K-H, Lu J-H, Li M. Targeting Aggrephagy for the Treatment of Alzheimer’s Disease. Cells. 2020; 9(2):311.

Chicago/Turabian Style

Malampati, Sandeep, Ju-Xian Song, Benjamin Chun-Kit Tong, Anusha Nalluri, Chuan-Bin Yang, Ziying Wang, Sravan Gopalkrishnashetty Sreenivasmurthy, Zhou Zhu, Jia Liu, Chengfu Su, Senthilkumar Krishnamoorthi, Ashok Iyaswamy, King-Ho Cheung, Jia-Hong Lu, and Min Li. 2020. "Targeting Aggrephagy for the Treatment of Alzheimer’s Disease" Cells 9, no. 2: 311.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop